Anticancer therapy with checkpoint inhibitors: what, where and when?
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference62 articles.
1. New insights into checkpoint kinase 1 in the DNA damaging response signalling network;Dai;Clin. Cancer Res.,2010
2. Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response;Stracker;DNA Repair,2009
3. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2;Reinhardt;Curr. Opin. Cell Biol.,2009
4. Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents;Leijen;Curr. Clin. Pharmacol.,2010
5. Targeted cancer therapies based on the inhibition of DNA strand break repair;O’Connor;Oncogene,2007
Cited by 186 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Correlation between Molecular Docking and the Stabilizing Interaction of HOMO-LUMO: Spirostans in CHK1 and CHK2, an In Silico Cancer Approach;International Journal of Molecular Sciences;2024-08-06
2. Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights;Bioorganic Chemistry;2024-08
3. Primary cancer prevention for cancers with no known infectious etiology: Time for a new paradigm;Vaccine;2024-03
4. Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer;npj Precision Oncology;2024-01-26
5. Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing tumour protein 53 gene status;Exploration of Targeted Anti-tumor Therapy;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3